Related Experiment Videos
Progressive impairment of CSF beta-EP levels in migraine sufferers
Andrea R Genazzani1, Giuseppe Nappi, Fabio Facchinetti
1Department of Obstetrics and Gynecology, University of Modena, Modena, Italy Department of Neurology, University of Pavia, PaviaItaly.
Abstract:
Common migraine (CM) is an evolutive disease characterized by a progressive increase in the number of attacks and a consequent reduction in the free periods, eventually reaching a state of continuous migraine with interparoxysmal headache (MIH). To evaluate the role of central pro-opiocortin-related peptides in the pathogenesis of the disease, cerebrospinal fluid (CSF) levels of beta-lipotropin (beta-LPH), beta-endorphin (beta-EP) and ACTH were measured in two groups of migraine sufferers with increasing severity of the disease (CM and MIH), and in healthy controls. ACTH values were similar in the 3 groups, while beta-LPH levels were significantly lower (P less than 0.005) in patients affected by MIH (10.4 +/- 8.6 fmol/ml) than in patients with CM (35.7 +/- 8.3) and in controls (32.9 +/- 15.33). beta-EP levels were closely correlated with the severity of the disease: they decreased significantly from those found in healthy controls (86.1 +/- 37 fmol/ml) to those of CM sufferers (38.5 +/- 3.5; P less than 0.005) and showed a further significant fall (P less than 0.01) to the lowest levels which were found in MIH patients (14.8 +/- 9.8). These data showing that the progressive evolution of migraine is concomitant with a progressive impairment in the CSF levels of beta-EP, sustain the concept that non-organic central pain is related to a reduced activity of the neurons responsible for the CSF content of beta-EP.
Insights
Levels of beta-endorphin (beta-EP) in cerebrospinal fluid (CSF) decrease as migraine severity increases, suggesting reduced beta-EP activity contributes to chronic migraine pain.
Area of Science:
- Neuroscience
- Endocrinology
- Pain Research
Background:
- Common migraine (CM) is a progressive neurological disorder.
- Migraine can evolve into chronic states like migraine with interparoxysmal headache (MIH).
- The role of central pro-opiocortin peptides in migraine pathogenesis is not fully understood.
Purpose of the Study:
- To investigate the role of central pro-opiocortin-related peptides in migraine evolution.
- To measure cerebrospinal fluid (CSF) levels of beta-lipotropin (beta-LPH), beta-endorphin (beta-EP), and ACTH in migraine patients and controls.
Main Methods:
- CSF samples were collected from patients with CM, MIH, and healthy controls.
- Levels of beta-LPH, beta-EP, and ACTH were quantified using immunoassays.
- Statistical analysis was performed to compare peptide levels across the groups.
Main Results:
- ACTH levels did not differ significantly among the groups.
- Beta-LPH levels were significantly lower in MIH patients compared to CM patients and controls.
- Beta-EP levels showed a significant progressive decrease from controls to CM and then to MIH patients, correlating with disease severity.
Conclusions:
- Progressive evolution of migraine is associated with declining CSF beta-EP levels.
- Reduced central beta-EP activity may be implicated in the pathogenesis of chronic migraine.
- These findings support the link between non-organic central pain and impaired beta-EP neuronal activity.